204 related articles for article (PubMed ID: 30418489)
1. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
[TBL] [Abstract][Full Text] [Related]
2. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
[TBL] [Abstract][Full Text] [Related]
3. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
[TBL] [Abstract][Full Text] [Related]
4. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
Croteau DL; Peng Y; Van Houten B
DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
[TBL] [Abstract][Full Text] [Related]
5. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
6. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
7. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2.
Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H
Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348
[TBL] [Abstract][Full Text] [Related]
8. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
Jiang H; Yang LY
Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
[TBL] [Abstract][Full Text] [Related]
10. The knock-down of ERCC1 but not of XPF causes multinucleation.
Rageul J; Frëmin C; Ezan F; Baffet G; Langouët S
DNA Repair (Amst); 2011 Sep; 10(9):978-90. PubMed ID: 21839691
[TBL] [Abstract][Full Text] [Related]
11. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
[TBL] [Abstract][Full Text] [Related]
13. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
[TBL] [Abstract][Full Text] [Related]
14. Regulation of DNA repair gene expression in human cancer cell lines.
McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
[TBL] [Abstract][Full Text] [Related]
15. A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair.
van den Heuvel D; Kim M; Wondergem AP; van der Meer PJ; Witkamp M; Lambregtse F; Kim HS; Kan F; Apelt K; Kragten A; González-Prieto R; Vertegaal ACO; Yeo JE; Kim BG; van Doorn R; Schärer OD; Luijsterburg MS
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2208860120. PubMed ID: 36893274
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation.
Musich PR; Li Z; Zou Y
Adv Exp Med Biol; 2017; 996():41-54. PubMed ID: 29124689
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein.
Nagai A; Saijo M; Kuraoka I; Matsuda T; Kodo N; Nakatsu Y; Mimaki T; Mino M; Biggerstaff M; Wood RD
Biochem Biophys Res Commun; 1995 Jun; 211(3):960-6. PubMed ID: 7598728
[TBL] [Abstract][Full Text] [Related]
19. The Nucleotide Excision Repair Pathway Limits L1 Retrotransposition.
Servant G; Streva VA; Derbes RS; Wijetunge MI; Neeland M; White TB; Belancio VP; Roy-Engel AM; Deininger PL
Genetics; 2017 Jan; 205(1):139-153. PubMed ID: 28049704
[TBL] [Abstract][Full Text] [Related]
20. Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.
Fadda E
Biophys J; 2013 Jun; 104(11):2503-11. PubMed ID: 23746523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
